BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Babson Diagnostics Announces Strategic Investment from BD

  October 8, 2024

   · 

  3 min read
• Press Releases

  Incyte to Report Third Quarter Financial Results

  October 8, 2024

   · 

  1 min read
• Press Releases

  Pierre Fabre Laboratories and Scorpion Therapeutics Announce First Patient Dosed in Phase I/II Clinical Trial of PFL-241/STX-241, a Mutant-Selective Inhibitor Intended to Treat Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  October 8, 2024

   · 

  6 min read
• Press Releases

  Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  October 8, 2024

   · 

  2 min read
• Press Releases

  Olfactive Biosolutions Granted Patent to Repurpose Food Molecules for Weight Loss and Blood Sugar Reduction

  October 8, 2024

   · 

  2 min read
• Press Releases

  Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002

  October 8, 2024

   · 

  4 min read
• Press Releases

  Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals

  October 8, 2024

   · 

  7 min read
• Press Releases

  Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC

  October 8, 2024

   · 

  1 min read
• Press Releases

  SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities

  October 8, 2024

   · 

  7 min read
• Press Releases

  Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial

  October 8, 2024

   · 

  8 min read